Recruiting

The Benefits of Home Exercise in Pulmonary Hypertension Interstitial Lung Disease

This study evaluates the effects of a structured home exercise program in participants with pulmonary hypertension associated with interstitial lung disease. Participants will complete a defined exercise regimen over a 16-week period, and functional capacity and patient reported outcomes will be assessed at baseline and after the intervention. The study aims to determine whether a home-based exercise approach is feasible and associated with improvements in functional performance.

ClinicalTrials.gov IDNCT07561034

PhaseNA

Enrollment30

SponsorUniversity of Rochester

Age18 Years

SexALL

I'm interested View official listing

Conditions studied

Pulmonary Hypertension, Interstitial Lung Disease

About this study

Interventions

Behavioral: Home Exercise Program, Aerobic Plus Strength Training — Structured home based exercise program delivered by daily SMS text message or email for 16 weeks, including aerobic and strength training activities with heart rate guidance.
Behavioral: Home Exercise Program, Aerobic Only — Structured home based exercise program delivered by daily SMS text message or email for 16 weeks, including aerobic activities with heart rate guidance.

Primary outcomes

Mean Change in Cardiac Effort From Baseline to 16 Weeks (Baseline to 16 weeks)

Eligibility information

Inclusion Criteria: * Follows at University of Rochester Medical Center Pulmonary Hypertension Clinic. * Adult patients (\>18 years old) with right heart catheterization confirmed pulmonary hypertension interstitial lung disease on stable therapy dosing for at least 30 days. * Access to a smart phone or email to receive daily messages. * Clinically stable by the investigator. Exclusion Criteria: * Pregnancy. * Pulmonary Hypertension Groups 1,2,4,5. * Resting tachycardia \>120 beats/m during screening. * Inability to walk. * WHO Functional Class IV * Lack of access to email or text messaging. * Participating in a rehabilitation program.

Study locations

University of Rochester Medical Center, Rochester, New York 14642 United States

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.